Sales rise 156.29% to Rs 8.15 crore
Net profit of Beryl Drugs reported to Rs 0.14 crore in the quarter ended December 2022 as against net loss of Rs 0.10 crore during the previous quarter ended December 2021. Sales rose 156.29% to Rs 8.15 crore in the quarter ended December 2022 as against Rs 3.18 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales8.153.18 156 OPM %8.717.86 -PBDT0.590.13 354 PBT0.37-0.14 LP NP0.14-0.10 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
